Pharmaceutical firms hesitant to sponsor scientific meetings

Business industry sources say that the recent revision of fair competition code emphasizing more tight control on the sponsorship of scientific meetings at home and abroad is bothering many domestic pharmaceutical firms, especially foreign-invested firms which regard the sponsorship as a major marketing tool.

Under the revised fair competition code, pharmaceutical companies, which intend to...